Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Sep 2023
Consolidate Net Profit
YoY Growth in quarter ended Sep 2024 is 15.87% vs 28.81% in Sep 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2024 is 23.58% vs 31.67% in Sep 2023
Interest
YoY Growth in quarter ended Sep 2024 is -30.00% vs 900.00% in Sep 2023
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2024 has improved from Sep 2023
Compare Quarterly Results Of Viracta Therapeutics, Inc. With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2024 is -8.16% vs -7.69% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 15.87% vs 28.81% in Sep 2023
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2024 is 1.05% vs 31.16% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 23.58% vs 31.67% in Sep 2023
Quarterly - Interest
QoQ Growth in quarter ended Sep 2024 is 0.00% vs -22.22% in Jun 2024
YoY Growth in quarter ended Sep 2024 is -30.00% vs 900.00% in Sep 2023






